Epitracker, Inc. is unlocking secrets long held by dolphins to help treat the world’s most devastating diseases. Combining metabolomics and big data analytics, Epitracker has discovered over one hundred smart-screened small molecules targeting aging associated diseases. Our lead compound, ETI-101, has demonstrated broad efficacy in alleviating inflammation, anemia, fibrosis and metabolic syndrome. Epitracker is currently building strategic partnerships with VCs and industry to advance ETI-101 and additional compounds for anti-aging, skin repair, and Alzheimer’s disease.